Chemicals and Life Sciences
M&A Director
M&A Director
Q2 2021
The newsletter for M&A and corporate development directors
of mid-market chemicals and life sciences businesses
of mid-market chemicals and life sciences businesses
Dear Reader,
Welcome to our second quarterly newsletter of 2021.
Deals are being done. Financial investors are looking to deploy capital and strategic leaders are adjusting their portfolios
2021 looks to set to be an interesting year for M&A and other related strategic initiatives.
Below we have collated corporate development data from the last quarter and thought-pieces on what the year ahead holds in store for the chemicals and life sciences industries.
Wishing everyone health and happiness,
Matt Dixon, CCD Partners
Featured Article - Steve Holland
Were strong 2020 results for chemical distributors a win-win for all stakeholders in the supply chain?
Chemical distributors delivered impressive results in 2020 during the Covid crisis, with increased margins and strong cash flow.
Former Brenntag Chairman and CEO Steve Holland
asks was it a win-win for all stakeholders in the supply chain?
Introducing the “Chemical Transformations Podcast: the art of unlocking sustainable commercial potential”
Welcome to CCD Partners’ newly launched Chemical Transformations podcast!
Businesses built on expertise in chemistry or biology often face unique challenges realising and sustaining their full commercial potential.
We will be interviewing dealmakers and business leaders to learn about the challenges they are facing and the strategies they have employed to get ahead and stay ahead.
In our inaugural episode, CCD Partners Managing Partner Matt Dixon and Senior Advisor Glenn McGuire discuss the sale of Chem32 to PQ Corporation, recent performance trends in the specialty chemicals markets, and how investor confidence has evolved a year on from the COVID-19 pandemic outbreak.
Deal Summary
Our focus is on the smaller private market deals that tend to be less reported in major publications. We have tracked more than 40 such M&A transaction announcements in the last quarter.
Our top six deals from last quarter are:
| Target | Buyer | Seller | Target Sector | Synopsis / Title |
|---|---|---|---|---|
| MKVN Chemicals | Azelis | Private | Chemical Distribution | Azelis acquires a majority shareholding in MKVN Chemicals and Viet Chemicals |
| VersaFlex | PPG | Private | Specialty Chemicals | PPG Industries acquires KCK manufacturer VersaFlex |
| CalChem | USALCO | Private | Specialty Chemicals | USALCO acquires AlChem and CalChem |
| Custom Chemical Services | LBB Specialties | Private | Chemical Distribution | LBB Specialties LLC Acquires Custom Chemical Services, Inc. |
| Tennants Fine Chemicals | Eternis Fine Chemicals | Private | Specialty Chemicals | Eternis Fine Chemicals Ltd Acquires Tennants Fine Chemicals |
| Chempro Group | Hextar | Private | Specialty Chemicals | Hextar acquires Chempro Group to expand chemical arm |
View full list
Sign up to our weekly trackerKey Appointments
We track the career movement of senior executives instrumental in shaping strategic organisational development through transformative transactions or other means.
Our top five moves from last quarter are:
| Name | From | To | Role |
|---|---|---|---|
| Stephen Oxley | KPMG | Johnson Matthey | CFO |
| Yan Beynon | Siemens Healthineers | Solvay | Entrepreneur & Chief Digital Officer |
| Jim Fitterling | Dow | 3M | Board of Directors |
| Daniele Ferrari | Versalis | SK Capital Partners | Senior Director |
| Thomas Gangl | OMV | Borealis | CEO |
View full list
Sign up to our weekly trackerPartner Insights
GLENN MCGUIRE
Senior Advisor
Chem32 acquired by PQ Corporation: how business owners can capitalise on a post-COVID uptick
Read full article
CCD Partners Senior Advisor Glenn McGuire recently advised on the acquisition by PQ Corporation of Chem32, a founder-led supplier of catalyst pre-activation services in the US.
Reflecting on current market conditions and the outlook for the year ahead, Glenn shares his thoughts on how the Chem32 deal is representative of a broader trend as M&A activity picks back up after the initial slowdown caused by the coronavirus pandemic.
Third Party Recommended Reading
Five trends that will shape the 2021 chemical industry
“So much has changed in just a year. Established strategies of the past are no longer relevant. The pandemic exposed industry weaknesses and significantly accelerated transformation programs. Here are five key trends that will shape 2021.”
Chemical industry leaders: We look to new EU industrial strategy to help us “put the wheels” on the Green Deal
“Policy coherence and regulatory predictability are the “one key thing” the EU chemical industry needs in order to help the EU achieve the EU Green Deal objectives.”
2021 outlook for life sciences: Six reasons the sector is stronger than ever
“When countries around the world began to lock down last spring, life sciences companies could have opted to minimize their risk, pull back on investments, and weather the storm. Instead, they headed directly into the eye of the hurricane. This led to the development of vaccines, as well as new distribution and tracking innovations.”
A winning formula for specialty-chemical conglomerates
“An analysis of top-quartile specialty-chemical companies reveals important implications for value creation.”
Not Signed Up Yet?
Subscribe to our quarterly newsletter
Please enter your email below to ensure you receive this newsletter on a quarterly basis.
For a more frequent update, our weekly top-five pick of global M&A and senior people moves is also available. To receive our "Chemical Highlights" updates please sign up here.
For more content from expert voices in our corporate development community, as well as our own thoughts and viewpoints, visit our
blog.
Contact Us
CCD Partners
Insight | Network | Execution
We are a network of multi-disciplinary specialists united in the common purpose of identifying and delivering the full potential of innovative and impactful chemicals and life sciences businesses.
Get In Touch
